Abbott Laboratories (TSX:ABT)

Abbott Laboratories Statistics

Total Valuation

TSX:ABT has a market cap or net worth of CAD 299.29 billion. The enterprise value is 306.89 billion.

Market Cap	299.29B
Enterprise Value	306.89B

Important Dates

The next estimated earnings date is Thursday, January 22, 2026.

Earnings Date	Jan 22, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.04%
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	0.48%
Owned by Institutions (%)	80.45%
Float	1.73B

Valuation Ratios

The trailing PE ratio is 15.43 and the forward PE ratio is 22.50.

PE Ratio	15.43
Forward PE	22.50
PS Ratio	4.90
PB Ratio	4.19
P/TBV Ratio	10.05
P/FCF Ratio	31.06
P/OCF Ratio	23.56
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.51, with an EV/FCF ratio of 31.85.

EV / Earnings	15.82
EV / Sales	5.12
EV / EBITDA	18.51
EV / EBIT	26.03
EV / FCF	31.85

Financial Position

The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.25.

Current Ratio	1.70
Quick Ratio	1.09
Debt / Equity	0.25
Debt / EBITDA	1.07
Debt / FCF	1.88
Interest Coverage	16.93

Financial Efficiency

Return on equity (ROE) is 30.62% and return on invested capital (ROIC) is 9.03%.

Return on Equity (ROE)	30.62%
Return on Assets (ROA)	6.79%
Return on Invested Capital (ROIC)	9.03%
Return on Capital Employed (ROCE)	12.38%
Revenue Per Employee	535,688
Profits Per Employee	170,153
Employee Count	114,000
Asset Turnover	0.55
Inventory Turnover	2.84

Taxes

Income Tax	-8.13B
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	1.05
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	994

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.50

Income Statement

In the last 12 months, TSX:ABT had revenue of CAD 61.07 billion and earned 19.40 billion in profits. Earnings per share was 11.09.

Revenue	61.07B
Gross Profit	34.36B
Operating Income	12.00B
Pretax Income	11.34B
Net Income	19.40B
EBITDA	16.36B
EBIT	12.00B
Earnings Per Share (EPS)	11.09

Balance Sheet

The company has 10.77 billion in cash and 18.07 billion in debt, giving a net cash position of -7.30 billion.

Cash & Cash Equivalents	10.77B
Total Debt	18.07B
Net Cash	-7.30B
Net Cash Per Share	n/a
Equity (Book Value)	71.41B
Book Value Per Share	40.82
Working Capital	14.29B

Cash Flow

In the last 12 months, operating cash flow was 12.70 billion and capital expenditures -3.07 billion, giving a free cash flow of 9.63 billion.

Operating Cash Flow	12.70B
Capital Expenditures	-3.07B
Free Cash Flow	9.63B
FCF Per Share	n/a

Margins

Gross margin is 56.26%, with operating and profit margins of 19.65% and 31.88%.

Gross Margin	56.26%
Operating Margin	19.65%
Pretax Margin	18.56%
Profit Margin	31.88%
EBITDA Margin	26.79%
EBIT Margin	19.65%
FCF Margin	15.78%

Dividends & Yields

TSX:ABT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	28.93%
Buyback Yield	0.04%
Shareholder Yield	0.04%
Earnings Yield	6.48%
FCF Yield	3.22%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:ABT has an Altman Z-Score of 5.83 and a Piotroski F-Score of 6.

Altman Z-Score	5.83
Piotroski F-Score	6